Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 15, 2019

View Archived Issues

ALKBH proteins are potential therapeutic targets in HNSCC

Novel GET zebrafish larvae model of invasive mycoses

GalNAc-siTAZ improves hepatic inflammation, fibrosis and liver damage in models of NASH

Targeting Piezo1 channel as promising new therapeutic strategy in prostate cancer

Reservoir grows when ART starts

Accidental immunity gives rotavirus insight

Ironing out regional differences affects anxiety

Patient enrollment under way in phase I study of FT-516

Matinas BioPharma initiates EnACT study of MAT-2203 for fungal cryptococcal meningitis

Wuhan Institute of Virology describes respiratory syncytial virus vaccine antigen

Novel PSMA-targeting 177-Lu radiolabeled compounds with outstanding tumor uptake presented

Recombinant Clonorchis sinensis heat shock cognate protein B patented by Xuzhou Medical University

Bristol-Myers Squibb identifies new TYK2 inhibitors

Intra-Cellular Therapies discovers 5-HT2A antagonists/mu-opioid receptor partial agonists

DE Shaw Research and Relay Therapeutics disclose PTPN11 inhibitors

Progression-free survival improved with ivosidenib in pivotal cholangiocarcinoma trial

NMSS grant supports Clene's development of nanocatalytic therapeutic CNM-Au8 for MS

Immunotherapy frontiers: 'Strength in numbers', 'it only takes one' both true for neoantigens

Primary endpoint met in registrational MOXIe trial of omaveloxolone for Friedreich's ataxia

Collaborative Medicinal Development enrolls first patient in new study of CuATSM for ALS

Viela Bio enrolling kidney transplant recipients for phase IIa trial of VIB-4920 and belatacept

AstraZeneca initiates first-in-human study of AZD-4041 in healthy volunteers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...